Literature DB >> 8616567

Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease.

C Agostini1, R Zambello, R Sancetta, A Cerutti, A Milani, C Tassinari, M Facco, A Cipriani, L Trentin, G Semenzato.   

Abstract

Recently, a novel receptor superfamily has been identified whose members interact with a parallel family of ligands showing homology to tumor necrosis factor (TNF). To investigate the role of these receptor structures in the pulmonary environment, we evaluated the expression of some members of the TNF-receptor (CD27, CD30, CD40, CD95/Fas, CD120a, and CD120b) and TNF-ligand (CD40L, CD70/CD27L, CD30L, and mTNFalpha) superfamilies by bronchoalveolar lavage (BAL) T cells recovered from healthy subjects and patients with interstitial lung disease (ILD). Lung T lymphocytes recovered from control subjects showed a slight expression of CD27 but did not bear CD30, CD40, CD120a, or CD120b antigens. CD27 expression was restricted to normal CD4+ cells. Fas antigen (CD95), which is involved in activation-driven T-cell suicide, and the ligand for CD27 (CD70) were weakly expressed by normal BAL T-cell subpopulations. In patients with sarcoidosis, the majority of pulmonary T lymphocytes were CD4+ cells that expressed low levels of CD27 antigen and an upregulation of CD95 and CD70 molecules. When we characterized lymphocytes accumulating in the lung of patients with HIV infection and hypersensitivity pneumonitis, we demonstrated that T cells accounting for the CD8 alveolitis bore TNF-receptor type 2 (CD120b) at high density and were CD70+ while CD40L, CD30L, or mTNF-alpha expression were not found. The discrete surface expression of the TNF-receptors and TNF-ligands on alveolar T-cell subsets suggests that these molecules play a role in the immune regulatory mechanisms that ultimately lead to the alveolitis in the pulmonary microenvironment of interstitial lung disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616567     DOI: 10.1164/ajrccm.153.4.8616567

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

1.  Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

Authors:  J Wahlström; M Berlin; C M Sköld; H Wigzell; A Eklund; J Grunewald
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans.

Authors:  Y S Wasfi; L J Silveira; A Jonth; J E Hokanson; T Fingerlin; H Sato; C E Parsons; P Lympany; K Welsh; R M du Bois; L S Newman; L A Maier
Journal:  Tissue Antigens       Date:  2008-07

3.  Lymphocyte dynamics: caution in interpreting BAL numbers.

Authors:  R Pabst; T Tschernig
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

Review 4.  Cells and molecules involved in the development of sarcoid granuloma.

Authors:  C Agostini; U Basso; G Semenzato
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

5.  Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis.

Authors:  H Stridh; A Planck; D Gigliotti; A Eklund; J Grunewald
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 6.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

7.  Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung.

Authors:  Godelieve J de Bree; Ester M M van Leeuwen; Theo A Out; Henk M Jansen; René E Jonkers; René A W van Lier
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

8.  Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.

Authors:  J Müller-Quernheim
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

9.  Impaired survival of regulatory T cells in pulmonary sarcoidosis.

Authors:  Caroline E Broos; Menno van Nimwegen; Alex Kleinjan; Bregje ten Berge; Femke Muskens; Johannes C C M in 't Veen; Jouke T Annema; Bart N Lambrecht; Henk C Hoogsteden; Rudi W Hendriks; Mirjam Kool; Bernt van den Blink
Journal:  Respir Res       Date:  2015-09-16

10.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.